BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21679737)

  • 1. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
    McConnell MJ; Rumbo C; Bou G; Pachón J
    Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.
    García-Quintanilla M; Pulido MR; Pachón J; McConnell MJ
    PLoS One; 2014; 9(12):e114410. PubMed ID: 25485716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.
    McConnell MJ; Pachón J
    Vaccine; 2010 Dec; 29(1):1-5. PubMed ID: 21044668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
    Badmasti F; Ajdary S; Bouzari S; Fooladi AA; Shahcheraghi F; Siadat SD
    Mol Immunol; 2015 Oct; 67(2 Pt B):552-8. PubMed ID: 26277277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.
    Pulido MR; García-Quintanilla M; Pachón J; McConnell MJ
    Vaccine; 2020 Jan; 38(4):719-724. PubMed ID: 31843268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
    Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
    Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
    Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Different Methods for Preparing
    Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
    Front Immunol; 2020; 11():1069. PubMed ID: 32655550
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
    KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
    Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with lipopolysaccharide-free outer membrane complexes protects against Acinetobacter baumannii infection.
    Pulido MR; García-Quintanilla M; Pachón J; McConnell MJ
    Vaccine; 2018 Jul; 36(29):4153-4156. PubMed ID: 29887323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii.
    Bolourchi N; Shahcheraghi F; Shirazi AS; Janani A; Bahrami F; Badmasti F
    Microb Pathog; 2019 Jun; 131():9-14. PubMed ID: 30930220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of an outer membrane protein that is antigenically specific for Acinetobacter baumannii.
    Islam AH; Singh KK; Ismail A
    Diagn Microbiol Infect Dis; 2011 Jan; 69(1):38-44. PubMed ID: 21146712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
    Garg N; Singh R; Shukla G; Capalash N; Sharma P
    Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
    Singh R; Capalash N; Sharma P
    Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First steps towards a vaccine against Acinetobacter baumannii.
    Garcia-Quintanilla M; Pulido MR; McConnell MJ
    Curr Pharm Biotechnol; 2013; 14(10):897-902. PubMed ID: 24372252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
    Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP
    Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii.
    McConnell MJ; Domínguez-Herrera J; Smani Y; López-Rojas R; Docobo-Pérez F; Pachón J
    Infect Immun; 2011 Jan; 79(1):518-26. PubMed ID: 20974823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
    Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
    Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid Antigens Expressing Surface Loops of ZnuD From
    Qamsari MM; Rasooli I; Chaudhuri S; Astaneh SDA; Schryvers AB
    Front Immunol; 2020; 11():158. PubMed ID: 32117294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.